SHBG is a serum glycoprotein that binds oestrogens and androgens with high affinity and specificity,16 thereby lowering the bioavailable fraction of these sex steroids and potentially reducing subsequent breast cancer risk. This evidence concerns the gene SHBG and breast cancer.